Trilogy Global Advisors’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
VAM
HL
Trilogy Global Advisors's ABEV Position: Q4 2018 in Review
Trilogy Global Advisors sold out of Ambev (ABEV) in Q4 2018, closing a stake of 3,216,671 shares — an estimated $14.7M sold.
Trilogy Global Advisors first reported a position in ABEV in Q4 2013 and held it in 20 quarters. The position peaked at $136M in Q2 2014. 318 funds tracked by Wall St. Rank hold ABEV as of Q4 2018.
- Trilogy Global Advisors reported no remaining Ambev position as of Q4 2018 after selling out during the quarter.
- Trilogy Global Advisors sold 3,216,671 Ambev shares in Q4 2018, an estimated $14.7M.
- Trilogy Global Advisors first reported a position in Ambev in Q4 2013 and held it in 20 quarters.
- Trilogy Global Advisors's Ambev position peaked at $136M in Q2 2014.
- 318 funds tracked by Wall St. Rank held Ambev as of Q4 2018.
Based on Trilogy Global Advisors's 13F filing for Q4 2018, filed 8 Feb 2019.